NNCSF
Price
$2.35
Change
-$0.30 (-11.32%)
Updated
Jun 23 closing price
Capitalization
962.45M
POCI
Price
$4.92
Change
+$0.35 (+7.66%)
Updated
Jun 27 closing price
Capitalization
34.71M
Interact to see
Advertisement

NNCSF vs POCI

Header iconNNCSF vs POCI Comparison
Open Charts NNCSF vs POCIBanner chart's image
Nanosonics
Price$2.35
Change-$0.30 (-11.32%)
Volume$6.48K
Capitalization962.45M
Precision Optics
Price$4.92
Change+$0.35 (+7.66%)
Volume$66.11K
Capitalization34.71M
NNCSF vs POCI Comparison Chart in %
Loading...
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NNCSF vs. POCI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NNCSF is a Hold and POCI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NNCSF: $2.35 vs. POCI: $4.92)
Brand notoriety: NNCSF and POCI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NNCSF: 199% vs. POCI: 238%
Market capitalization -- NNCSF: $962.45M vs. POCI: $34.71M
NNCSF [@Medical Specialties] is valued at $962.45M. POCI’s [@Medical Specialties] market capitalization is $34.71M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NNCSF’s FA Score shows that 1 FA rating(s) are green whilePOCI’s FA Score has 1 green FA rating(s).

  • NNCSF’s FA Score: 1 green, 4 red.
  • POCI’s FA Score: 1 green, 4 red.
According to our system of comparison, both NNCSF and POCI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NNCSF’s TA Score shows that 3 TA indicator(s) are bullish while POCI’s TA Score has 4 bullish TA indicator(s).

  • NNCSF’s TA Score: 3 bullish, 4 bearish.
  • POCI’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, POCI is a better buy in the short-term than NNCSF.

Price Growth

NNCSF (@Medical Specialties) experienced а -11.32% price change this week, while POCI (@Medical Specialties) price change was +12.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NNCSF($962M) has a higher market cap than POCI($34.7M). POCI has higher P/E ratio than NNCSF: POCI (149.25) vs NNCSF (138.89). NNCSF YTD gains are higher at: 11.905 vs. POCI (2.075). NNCSF has higher annual earnings (EBITDA): 17.1M vs. POCI (-1.29M). NNCSF has more cash in the bank: 94.5M vs. POCI (987K). POCI has less debt than NNCSF: POCI (2.8M) vs NNCSF (11.7M). NNCSF has higher revenues than POCI: NNCSF (142M) vs POCI (19.2M).
NNCSFPOCINNCSF / POCI
Capitalization962M34.7M2,772%
EBITDA17.1M-1.29M-1,323%
Gain YTD11.9052.075574%
P/E Ratio138.89149.2593%
Revenue142M19.2M740%
Total Cash94.5M987K9,574%
Total Debt11.7M2.8M418%
FUNDAMENTALS RATINGS
NNCSF vs POCI: Fundamental Ratings
NNCSF
POCI
OUTLOOK RATING
1..100
5085
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
6997
PRICE GROWTH RATING
1..100
6251
P/E GROWTH RATING
1..100
303
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

POCI's Valuation (87) in the null industry is in the same range as NNCSF (94). This means that POCI’s stock grew similarly to NNCSF’s over the last 12 months.

POCI's Profit vs Risk Rating (85) in the null industry is in the same range as NNCSF (100). This means that POCI’s stock grew similarly to NNCSF’s over the last 12 months.

NNCSF's SMR Rating (69) in the null industry is in the same range as POCI (97). This means that NNCSF’s stock grew similarly to POCI’s over the last 12 months.

POCI's Price Growth Rating (51) in the null industry is in the same range as NNCSF (62). This means that POCI’s stock grew similarly to NNCSF’s over the last 12 months.

POCI's P/E Growth Rating (3) in the null industry is in the same range as NNCSF (30). This means that POCI’s stock grew similarly to NNCSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NNCSFPOCI
RSI
ODDS (%)
Bullish Trend 3 days ago
58%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
66%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSG8.560.32
+3.88%
Inseego Corp
ATUS2.130.01
+0.47%
Altice USA
HCA379.301.64
+0.43%
HCA Healthcare
AFCG4.76-0.06
-1.24%
Advanced Flower Capital Inc
TLX16.00-0.40
-2.44%
Telix Pharmaceuticals Ltd.

NNCSF and

Correlation & Price change

A.I.dvisor tells us that NNCSF and MBGNF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and MBGNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNCSF
1D Price
Change %
NNCSF100%
N/A
MBGNF - NNCSF
23%
Poorly correlated
N/A
NHNKY - NNCSF
8%
Poorly correlated
+1.27%
NVYTF - NNCSF
7%
Poorly correlated
N/A
POCI - NNCSF
1%
Poorly correlated
+7.66%
MCRPF - NNCSF
1%
Poorly correlated
N/A
More

POCI and

Correlation & Price change

A.I.dvisor tells us that POCI and MLSS have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POCI and MLSS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POCI
1D Price
Change %
POCI100%
+7.66%
MLSS - POCI
22%
Poorly correlated
-4.34%
NEPH - POCI
22%
Poorly correlated
-8.96%
WRBY - POCI
21%
Poorly correlated
+1.91%
BJDX - POCI
20%
Poorly correlated
+3.85%
RPID - POCI
20%
Poorly correlated
+2.87%
More